Methylated circulating tumor DNA in blood: power in cancer prognosis and response
about
Circulating unmethylated insulin DNA as a potential non-invasive biomarker of beta cell death in type 1 Diabetes: a review and future prospect.Circulating Tumor DNA as Biomarkers for Cancer Detection.Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine.Role of Epigenetics in Biology and Human Diseases.Future perspectives of circulating tumor DNA in colorectal cancer.DNA methylation signatures in circulating cell-free DNA as biomarkers for the early detection of cancer.Profiling lung adenocarcinoma by liquid biopsy: can one size fit all?Noninvasive strategies for breast cancer early detection.How to stomach an epigenetic insult: the gastric cancer epigenome.Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma.High levels of circulating folate concentrations are associated with DNA methylation of tumor suppressor and repair genes p16, MLH1, and MGMT in elderly Chileans.DNA hypomethylation of CBS promoter induced by folate deficiency is a potential noninvasive circulating biomarker for colorectal adenocarcinomas.Aberrant Promoter Methylation of Protocadherin8 (PCDH8) in Serum is a Potential Prognostic Marker for Low Gleason Score Prostate Cancer.Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker.Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients.Value of CNRIP1 promoter methylation in colorectal cancer screening and prognosis assessment and its influence on the activity of cancer cells.The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer.Methylation patterns in serum DNA for early identification of disseminated breast cancer.A Summary of the Biological Processes, Disease-Associated Changes, and Clinical Applications of DNA Methylation.Liquid biomarkers in melanoma: detection and discovery.Utility of urinary circulating tumor DNA for EGFR mutation detection in different stages of non-small cell lung cancer patients.Evaluation of Streck BCT and PAXgene Stabilised Blood Collection Tubes for Cell-Free Circulating DNA Studies in Plasma.Focused Ultrasound-enabled Brain Tumor Liquid Biopsy.Circulating free DNA in the era of precision oncology: Pre- and post-analytical concerns.Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer.Is CBOP/BEP an alternative to BEP for patients with poor prognosis metastatic germ cell tumours?Liquid biopsy in pancreatic cancer: the beginning of a new era.Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review)Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy
P2860
Q33604619-A3F5198E-59C5-462C-8598-BF3F8C59D615Q33632125-F8947D77-A49B-4B89-ACD4-F9097FE0B6CCQ33823065-B0D0CBA2-E14E-4BFA-97CF-9FE9AC278B8BQ37358791-3576EE6A-AF8C-4E81-83D6-CC28EE520482Q38685749-068A089E-90A9-48C7-91A6-F8E930560800Q38773645-71FC5F08-5756-4268-B14E-008D73AC12C4Q38785389-A5344B41-ACDE-4D98-BE10-EBAEC7C2BF2FQ38885953-3F524B76-5AAE-47DB-9164-DB009843B82CQ39312802-56D03353-FEAE-43B3-836C-D580ABADB619Q41035533-74C29DFA-770F-43F7-BED7-BE51E6184BD8Q41111394-66F0505A-75FC-456B-A1DF-1467FBADE109Q41612795-A101C33C-51D2-4C17-8AC9-FDCFD70BD90AQ42651317-69066968-9260-4A06-A56D-21202EBBC265Q46670174-AA827ED0-792E-40B4-A848-C22BA586D0B3Q47106167-A13CA075-4A85-464C-B6AA-1239EE5FA79AQ47109927-1444B45B-1B76-40A5-B9F8-88C5BD7C26C2Q47140501-4B8CDAE6-8D5D-432E-9189-7DA90D5041A5Q47151765-F042FF16-28D0-46BC-AD29-A697DFEFB639Q47264910-17347FC4-3B7E-4858-B6D8-B04E043CAED7Q47726847-25030A8D-B47B-4C72-8F1F-2C0D86A8C8E6Q47893937-A4968DB2-AD07-4048-80FF-75A172468EC9Q48253205-2C570735-CA6B-46A3-B514-9D0306E996D8Q52560196-FC8DAC72-241A-4D63-AC89-6D0FB3108BC4Q53721511-9ABFAC7B-1BA6-43E1-95AA-87F7C9BE0692Q55023953-ADFA1D56-F779-414A-A1AB-060E10252267Q55070614-3765C932-5C5E-4036-8C12-59D34F41A1A7Q55187959-D87E36A6-91EA-4DBB-8476-0F184F740F48Q58799160-B17E35B0-70F9-4357-8943-63ADBB5147F4Q59133974-C3FBFDFF-DA6E-4CC6-B351-847C82F159AB
P2860
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
@ast
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
@en
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
@nl
type
label
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
@ast
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
@en
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
@nl
prefLabel
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
@ast
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
@en
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
@nl
P2860
P3181
P356
P1476
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
@en
P2093
Goli Samimi
Kristina Warton
P2860
P304
P3181
P356
10.1530/ERC-15-0369
P407
P50
P5008
P577
2016-01-13T00:00:00Z